Concepedia

Zhendong Chen

ZC

Statistics

Publications

9

Citations

488

H-Index

9

Active since

2004

Affiliations

Sun Yat-sen University(Current)

Second Affiliated Hospital of Anhui Medical University

Hunan Cancer Hospital

Anhui Medical University

Liaoning Cancer Hospital & Institute

Zhendong Chen is an author at Sun Yat-sen University specializing in medicine, oncology, and cancer pharmacology.

Publications per year

2004–2025

9

Publications

9

Resveratrol inhibits TCDD-induced expression of CYP1A1 and CYP1B1 and catechol estrogen-mediated oxidative DNA damage in cultured human mammary epithelial cells

Zhendong Chen · Carcinogenesis · 2004 · 173 citations · Full text

, , +15

Pemetrexed versus gefitinib as a second-line treatment in advanced nonsquamous nonsmall-cell lung cancer patients harboring wild-type EGFR (CTONG0806): a multicenter randomized trial

Qing Zhou, Ying Cheng, Jin‐Ji Yang et al. · Annals of Oncology · 2014 · 69 citations · Full text

, , +15

Nimotuzumab Plus Gemcitabine for K-Ras Wild-Type Locally Advanced or Metastatic Pancreatic Cancer

Shukui Qin, Jin Li, Yuxian Bai et al. · Journal of Clinical Oncology · 2023 · 54 citations · Full text

, , +17

First-line sugemalimab with chemotherapy for advanced esophageal squamous cell carcinoma: a randomized phase 3 study

Jin Li, Zhendong Chen, Yuxian Bai et al. · Nature Medicine · 2024 · 51 citations

, , +7

Prognostic significance of cyclinD1 amplification and the co-alteration of cyclinD1/pRb/ppRb in patients with esophageal squamous cell carcinoma

M.-T. Wang, G. Chen, S.-J. An et al. · Diseases of the Esophagus · 2011 · 39 citations · Full text

, , +16

1–5 of 9